Skip to content

In the BioHarmony Drug Report Database

Amifampridine

Ruzurgi, Firdapse, Zenas (amifampridine) is a small molecule pharmaceutical. Amifampridine was first approved as Ruzurgi on 2009-12-23. It is used to treat lambert-eaton myasthenic syndrome in the USA. It has been approved in Europe to treat lambert-eaton myasthenic syndrome.
Trade Name Firdapse, Zenas
Common Name Amifampridine
Indication lambert-eaton myasthenic syndrome
Drug Class
Amifampridine
Get full access now